🐜
|
Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination--an impact of immunosenescence.
8 auth.
P. Trzonkowski,
J. Myśliwska,
E. Szmit,
J. Więckiewicz,
K. Lukaszuk,
L. Brydak,
...
M. Machała,
A. Myśliwski
|
8 |
2003 |
8 🐜
|
🐜
|
Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study.
11 auth.
A. Ciszewski,
Z. Bilińska,
L. Brydak,
C. Kepka,
M. Kruk,
M. Romanowska,
...
E. Księżycka,
J. Przyłuski,
W. Piotrowski,
Renata Mączyńska,
W. Rużyłło
|
7 |
2008 |
7 🐜
|
🐜
|
Immune consequences of the spontaneous pro-inflammatory status in depressed elderly patients
10 auth.
P. Trzonkowski,
J. Myśliwska,
B. Godlewska,
E. Szmit,
K. Łukaszuk,
J. Więckiewicz,
...
L. Brydak,
M. Machała,
J. Landowski,
A. Myśliwski
|
6 |
2004 |
6 🐜
|
🐬
|
Immunomodulating effect of influenza vaccination in the elderly differing in health status
J. Myśliwska,
P. Trzonkowski,
E. Szmit,
L. Brydak,
M. Machała,
Andrzej Myśliwski
|
6 |
2004 |
6 🐬
|
🐜
|
Anti-influenza vaccination in systemic lupus erythematosus patients: an analysis of specific humoral response and vaccination safety
7 auth.
Ewa Więsik-Szewczyk,
M. Romanowska,
P. Mielnik,
H. Chwalińska-Sadowska,
L. Brydak,
M. Olesińska,
...
J. Ząbek
|
6 |
2010 |
6 🐜
|
🦁
|
Humoral Immune Response to Influenza Vaccination in Patients from High Risk Groups
L. Brydak,
M. Machała
|
5 |
2000 |
5 🦁
|
🐬
|
Immune Response to Influenza Vaccination in an Elderly Population
L. Brydak,
M. Machała,
J. Myśliwska,
A. Myśliwski,
P. Trzonkowski
|
5 |
2003 |
5 🐬
|
🦁
|
Immunogenicity of influenza vaccine in patients with hemato-oncological disorders.
L. Brydak,
M. Całbecka
|
5 |
1999 |
5 🦁
|
🦁
|
Antibody response to influenza immunization in two consecutive epidemic seasons in patients with renal diseases.
L. Brydak,
M. Roszkowska–Blaim,
M. Machała,
B. Leszczyńska,
M. Sieniawska
|
5 |
2000 |
5 🦁
|
🦁
|
Humoral response to hemagglutinin components of influenza vaccine in patients with non-Hodgkin malignant lymphoma.
L. Brydak,
M. Machała,
P. Centkowski,
K. Warzocha,
Przemysław Biliński
|
5 |
2006 |
5 🦁
|